HK1053062A1 - 胰島素的經鼻吸收用製劑 - Google Patents

胰島素的經鼻吸收用製劑

Info

Publication number
HK1053062A1
HK1053062A1 HK03105361.7A HK03105361A HK1053062A1 HK 1053062 A1 HK1053062 A1 HK 1053062A1 HK 03105361 A HK03105361 A HK 03105361A HK 1053062 A1 HK1053062 A1 HK 1053062A1
Authority
HK
Hong Kong
Prior art keywords
pernasally
insulin preparations
absorbable
absorbable insulin
preparations
Prior art date
Application number
HK03105361.7A
Other languages
English (en)
Inventor
Nagata Ryoichi
Original Assignee
Translational Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Translational Res Ltd filed Critical Translational Res Ltd
Publication of HK1053062A1 publication Critical patent/HK1053062A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HK03105361.7A 2000-05-02 2003-07-24 胰島素的經鼻吸收用製劑 HK1053062A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000133289A JP2001316286A (ja) 2000-05-02 2000-05-02 インスリンの経鼻吸収用製剤
PCT/JP2001/003642 WO2001082950A1 (fr) 2000-05-02 2001-04-26 Preparations d'insuline pouvant etre absorbees par voie pernasale

Publications (1)

Publication Number Publication Date
HK1053062A1 true HK1053062A1 (zh) 2003-10-10

Family

ID=18641812

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03105361.7A HK1053062A1 (zh) 2000-05-02 2003-07-24 胰島素的經鼻吸收用製劑

Country Status (8)

Country Link
US (1) US6911213B2 (zh)
EP (1) EP1279403A1 (zh)
JP (1) JP2001316286A (zh)
KR (1) KR20020023233A (zh)
CN (1) CN1372472A (zh)
CA (1) CA2378001A1 (zh)
HK (1) HK1053062A1 (zh)
WO (1) WO2001082950A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4124734B2 (ja) * 2001-11-26 2008-07-23 アスビオファーマ株式会社 経鼻吸収用医薬組成物
WO2004113332A1 (ja) * 2003-06-19 2004-12-29 Ono Pharmaceutical Co., Ltd. 経鼻製剤
US7115561B2 (en) 2004-09-22 2006-10-03 Patterson James A Medicament composition and method of administration
CN103099777B (zh) * 2011-11-15 2014-05-07 上海高科生物工程有限公司 以多孔碳酸钙为载体的生物酶水凝胶剂及制备方法
US10722596B2 (en) * 2015-05-21 2020-07-28 Technion Research & Development Foundation Limited Crystals as hosts for entrapment and slow release of compounds
CN106138011B (zh) * 2016-08-05 2018-12-25 浙江理工大学 碳酸钙/透明质酸复合药物载体及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62223131A (ja) * 1986-03-26 1987-10-01 Nitto Electric Ind Co Ltd 持続性鼻疾患治療剤
JP3414539B2 (ja) 1994-05-11 2003-06-09 有限会社ドット 経鼻吸収用組成物
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
JPH11322582A (ja) * 1998-05-06 1999-11-24 Dot:Kk 経鼻吸収用鼻粘膜付着・滞留型キャリヤ
US6197328B1 (en) * 1999-08-20 2001-03-06 Dott Research Laboratory Nasally administrable compositions

Also Published As

Publication number Publication date
WO2001082950A1 (fr) 2001-11-08
CA2378001A1 (en) 2001-11-08
US6911213B2 (en) 2005-06-28
CN1372472A (zh) 2002-10-02
KR20020023233A (ko) 2002-03-28
EP1279403A1 (en) 2003-01-29
JP2001316286A (ja) 2001-11-13
US20030082240A1 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
AU5201901A (en) Single use syringe
CZ20011229A3 (cs) Opthalmologické prostředky
AU6282901A (en) Medical arrangement
IL186608A0 (en) Igf-like insulin variant
EP1260230A4 (en) LONG-TERM STABILIZED PREPARATIONS
PL359416A1 (en) Medicine comprising dicyanopyridine derivative
GB0009591D0 (en) Medical combinations
HK1068812A1 (en) Drug preparations
AU2001274548A1 (en) Syringe
AU2001278755A1 (en) Injections
AU8260701A (en) Solution preparations stabilized over long time
EP1264611A4 (en) SYRINGE
AU2001282607A1 (en) Solution preparations stabilized over long time
EP1268518A4 (en) INSULIN POTENTIALIZER PEPTIDES
AP2003002783A0 (en) Medicament containing activted antihtrombin iii
GB9928607D0 (en) Syringes
HK1053062A1 (zh) 胰島素的經鼻吸收用製劑
GB0030541D0 (en) Medical uses
AU2001260236A1 (en) Restricted use syringe
AU8252101A (en) Oct preparations
AU2000279374A1 (en) Secure syringe
GB0016585D0 (en) Syringe
AU4394201A (en) Insulin potentiating peptides
CA85594S (en) Syringe
GB0017092D0 (en) Medicament